“Iran's Medicine Crisis: Soaring Prices and Shortages Under US Sanctions” — what this page in the network covers. Medication prices in Iran are skyrocketing, and essential treatments are increasingly hard to find, leaving patients and their families in desperate situations as a US blockade and intensified sanctions cripple the country's pharmaceutical industry. The economic pressure has disrupted supply chains, making it difficult for Iran to import raw materials and finished drugs, while domestic production struggles to meet demand. The crisis has forced many Iranians to choose between paying exorbitant prices for life-saving medications or going without.
Some have resorted to black markets or cross-border purchases, but these options are risky and unsustainable. The shortage is particularly acute for patients with chronic conditions such as cancer, diabetes, and rare diseases, who rely on consistent access to specialized drugs. The full version stays on the original page, which this listing opens directly.